Engineered Immune Cells Move From Cancer Care Toward the Clinic Against Infections
A new review in the Journal of Translational Medicine charts how CAR-T-cell technology is being adapted from cancer treatment to ...
A new review in the Journal of Translational Medicine charts how CAR-T-cell technology is being adapted from cancer treatment to ...
New research shows that blocking the TREM2 receptor reprograms HER2-targeted CAR macrophages from suppressive to inflammatory, tumor-engulfing cells in breast ...
A large single-center study found that nearly 58 percent of patients undergoing hematopoietic cell transplantation or CAR-T therapy develop orthostatic ...
Researchers report that the membrane protein TSPAN32 enhances CAR-T cell potency by assembling the IL-2 receptor complex and amplifying intracellular ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine